CIGLIANO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 728
AS - Asia 717
EU - Europa 151
Continente sconosciuto - Info sul continente non disponibili 123
SA - Sud America 57
AF - Africa 9
Totale 1.785
Nazione #
US - Stati Uniti d'America 678
BD - Bangladesh 208
CN - Cina 175
SG - Singapore 164
IT - Italia 132
HK - Hong Kong 80
BR - Brasile 40
VN - Vietnam 26
MX - Messico 21
CA - Canada 17
IN - India 15
ID - Indonesia 9
AR - Argentina 7
PH - Filippine 7
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
SA - Arabia Saudita 4
TR - Turchia 4
VE - Venezuela 4
DE - Germania 3
ES - Italia 3
HN - Honduras 3
IQ - Iraq 3
MY - Malesia 3
TH - Thailandia 3
CR - Costa Rica 2
EG - Egitto 2
GB - Regno Unito 2
GR - Grecia 2
GT - Guatemala 2
JP - Giappone 2
MA - Marocco 2
RS - Serbia 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CD - Congo 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 1.662
Città #
San Jose 385
Ashburn 132
Singapore 82
Hong Kong 78
Beijing 66
Santa Clara 23
New York 20
Mexico City 17
Milan 17
Rome 14
Los Angeles 13
Ho Chi Minh City 11
Buffalo 8
Hanoi 8
Naples 7
Turin 6
Dallas 5
Toronto 5
Charlotte 4
Figino 4
Florence 4
Bangkok 3
Bologna 3
Chicago 3
Jeddah 3
Karachi 3
Medellín 3
Nuremberg 3
Parma 3
Shanghai 3
São Paulo 3
Bari 2
Brescia 2
Cagliari 2
Cairo 2
Caracas 2
Chennai 2
Forlì 2
Genoa 2
Germantown 2
Guatemala City 2
Istanbul 2
Madrid 2
Montreal 2
Nagoya 2
Palermo 2
Pasadena 2
Perugia 2
Philadelphia 2
Phoenix 2
Pátrai 2
San José 2
Uberlândia 2
Vadodara 2
Addis Ababa 1
Aguascalientes 1
Ancona 1
Antakya 1
Atibaia 1
Atlanta 1
Austin 1
Baghdad 1
Baku 1
Banatska Topola 1
Barbosa Ferraz 1
Bardhaman 1
Barquisimeto 1
Bauru 1
Belgrade 1
Belo Horizonte 1
Benátky nad Jizerou 1
Bełchatów 1
Bogor 1
Borgo Virgilio 1
Boston 1
Bradenton 1
Buenos Aires 1
Burzaco 1
Byblos 1
Bāndarban 1
Bến Tre 1
Cabanatuan City 1
Cagayan de Oro 1
Caloocan 1
Campiglione 1
Campo Largo 1
Campobasso 1
Careaçu 1
Cascina 1
Catania 1
Charlemont 1
Cidade Ocidental 1
City of Muntinlupa 1
Compton 1
Concordia 1
Cornwall 1
Cranbrook 1
Curitiba 1
Dakhla 1
Dammam 1
Totale 1.031
Nome #
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 67
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 61
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 37
The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans 35
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment 34
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade 32
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma 30
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 26
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 26
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans 26
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis 25
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 24
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease 24
Role of the Notch signaling in cholangiocarcinoma 23
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 23
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma 23
Current challenges to underpinning the genetic basis for cholangiocarcinoma 21
Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis 21
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 20
Apolipoprotein profiles in atherosclerotic disease 19
Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021)) 19
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 19
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 19
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice 18
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis 18
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 18
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 17
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 16
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men 16
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells 16
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 16
Functional role of SGK3 in PI3K/Pten driven liver tumor development 16
Pivotal role of fatty acid synthase in c-myc driven hepatocarcinogenesis 15
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 15
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 15
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 15
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 15
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice 15
Apolipoprotein Profiles in Atherosclerotic Disease 15
Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice 15
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice 15
Hepatocellular glycogenotic foci after combined intraportal pancreatic islet transplantation and knockout of the carbohydrate responsive element binding protein in diabetic mice 15
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice 14
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 14
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 14
Glycosaminoglycans and fabry’s disease 14
Studio del polimorfismo fenotipico e genetico di Apo E negli ovi-caprini sardi 14
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 14
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 14
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 14
Apolipoprotein E phenotyping in ovis species by isoelectric focusing and immunoblotting 13
Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis 13
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 13
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 13
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 13
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 13
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 13
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 13
Glycosaminoglycan content and distribution in human normal and varicose veins 12
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 12
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 12
Apolipoprotein Profiles in Atherosclerotic Disease 12
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice 12
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma 12
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 12
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 12
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 12
Structural analysis of Glycosaminoglycans from fresh porcine aortic valves 12
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 12
Apolipoprotein profiles in atherosclerotic disease 12
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 11
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 11
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 11
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 11
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 11
Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique 11
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 11
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 11
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 11
TAZ is indispensable for c-MYC-induced hepatocarcinogenesis 11
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 11
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 11
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma 11
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 10
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 10
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways 10
Glycosaminoglycan content and distribution in human normal and varicose veins 10
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 10
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 10
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 10
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair 10
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 10
Loss of pten synergizes with c-met to promote hepatocellular carcinoma development via mTORC2 pathway 9
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 9
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma 9
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 9
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism 9
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer 9
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 9
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 9
Totale 1.620
Categoria #
all - tutte 8.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.644 0 0 0 8 228 101 41 205 512 121 299 129
2026/2027141 60 72 9 0 0 0 0 0 0 0 0 0
Totale 1.785